Your search returned 5 results.

Results
	1.	Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin. [electronic resource] by Kadokura, Takeshi Groenendaal, Dorien Heeringa, Marten Mol, Roelof Verheggen, Frank Garcia-Hernandez, Alberto Onkels, Hartmut Producer: 20140703 In: European journal of drug metabolism and pharmacokinetics vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The pharmacokinetics of darexaban are not affected to a clinically relevant degree by rifampicin, a strong inducer of P-glycoprotein and CYP3A4. [electronic resource] by Groenendaal, Dorien Strabach, Gregory Garcia-Hernandez, Alberto Kadokura, Takeshi Heeringa, Marten Mol, Roelof Eltink, Charlotte Onkels, Hartmut Producer: 20130701 In: British journal of clinical pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The pharmacokinetics of darexaban (YM150), an oral direct factor Xa inhibitor, are not affected by ketoconazole, a strong inhibitor of CYP3A and P-glycoprotein. [electronic resource] by Groenendaal, Dorien Strabach, Gregory Garcia-Hernandez, Alberto Kadokura, Takeshi Heeringa, Marten Mol, Roelof Eltink, Charlotte Onkels, Hartmut Producer: 20180122 In: Clinical pharmacology in drug development vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects. [electronic resource] by Kadokura, Takeshi Kashiwa, Makoto Groenendaal, Dorien Heeringa, Marten Mol, Roelof Verheggen, Frank Garcia-Hernandez, Alberto Onkels, Hartmut Producer: 20140529 In: Biopharmaceutics & drug disposition vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Absorption, metabolism and excretion of darexaban (YM150), a new direct factor Xa inhibitor in humans. [electronic resource] by Hashimoto, Tadashi Suzuki, Katsuhiro Kihara, Yukie Iwatsubo, Takafumi Miyashita, Aiji Heeringa, Marten Onkels, Hartmut Groenendaal, Dorien Verheggen, Frank van Marle, Sjoerd Usui, Takashi Producer: 20140422 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)